 |
|
 |
| Rating: |
 |
| Value: |
|
| Tolerance: |
|
|
Product description: |
| Bontril is the brand
name of Phendimetrazine,
produced by Carnrick Laboratories Inc. Bontril is an appetite
suppressant and central nervous system stimulant. It stimulates
the satiety (feeling of fullness) centre in the hypothalamus
and limbic regions of the brain. Bontril must be used in combination
with a low calorie diet, behaviour modification and regular
exercise. Appetite suppressants
are not a substitute for proper diet. If any weight is lost
using Bontril, our research shows that it is usually regained
shortly after the patient discontinues the medication. |
Side effects: |
| Bontril has caused different side effects like restlessness, anxiety, dizziness, headache, insomnia, diarrhea, dry mouth and changes in the patients sex drive, allergic reactions (difficulty breathing, closing of the throat, swelling of lips or tongue), hallucinations, extreme hypertension, chest pain, pounding heart and difficulty urinating. Bontril can also be habit forming. You can become physically and psychologically dependent on this medication, and withdrawal effects may occur if you stop taking it. |
|
|
|
|
|
